Rationale of chemotherapeutic adjuvant treatment.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002330:Carmustine / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007939:Leukemia L1210 / Q000188:drug therapy / Q000473:pathology; D008130:Lomustine / Q000008:administration & dosage / Q000031:analogs & derivatives; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D008130:Lomustine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D005472:Fluorouracil; D002330:Carmustine; D008727:Methotrexate